Midlife mental distress and risk for dementia up to 27 years later: The Nord-Trøndelag Health Study (HUNT) in linkage with a dementia registry in Norway

BMC Geriatrics

Volumn 15, Issue 1, 2015, Pages

  Skogen, Jens Christoffer ^a,b,c   Bergh, Sverre ^d   Stewart, Robert ^e   Knudsen, Ann Kristin ^a,c   Bjerkeset, Ottar ^f  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d INNLANDET HOSPITAL TRUST   (Norway)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f NORD UNIVERSITY   (Norway)

Author keywords

Anxiety; Dementia; Depression; Midlife mental distress; Midlife risk

Indexed keywords

ADULT; AGED; DEMENTIA; FEMALE; HUMAN; MALE; MENTAL STRESS; MIDDLE AGED; NORWAY; ODDS RATIO; PSYCHOLOGY; REGISTER; RISK FACTOR; SELF REPORT; STATISTICAL MODEL; TIME FACTOR;

ADULT; AGED; DEMENTIA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NORWAY; ODDS RATIO; REGISTRIES; RISK FACTORS; SELF REPORT; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 84928710171     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/s12877-015-0020-5     Document Type: Article

References (72)

1. Burns A, Lliffe S. Dementia. BMJ. 2009;338:405-9.
2. Hofman A, Rocca WA, Brayne C, Breteler MMB, Clarke M, Cooper B, et al. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Int J Epidemiol. 1991;20(3):736-48.
3. Henderson AS. The coming epidemic of dementia. Aust N Z J Psychiatry. 1983;17:117-27.
4. Román GC. Stroke, cognitive decline and vascular dementia: the silent epidemic of the 21st century. Neuroepidemiology. 2003;22:161-7.
5. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3:186-91.
6. WHO. The global burden of disease: 2004 update. Geneva: World Health Organization; 2004.
7. WHO. Measuring the global burden of disease and risk factors, 1990-2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global burden of disease and risk factors. Geneva: World Health Organization; 2006.
8. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-223.
9. Lyons D, McLoughlin DM. Recent advances: psychiatry. BMJ. 2001;323:1228-31.
10. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112-7.
11. Wilson RS, Leurgans SE, Boyle PA, Bennett DA. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011;68(3):351-6.
12. Amieva H, Le Goff M, Millet X, Orgogozo JM, Pérès K, Barberger-Gateau P, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64(5):492-8.
13. Meyer JS, Xu G, Thornby J, Chowdhury MH, Quach M. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease? Stroke. 2002;33(8):1981-5.
14. van der Flier WM, Scheltens P. Epidemiology and risk factors for dementia. J Neurol Neurosurg Psychiatry. 2005;76:v2-7.
15. McCullagh CD, Craig D, McIlroy SP, Passmore AP. Risk factors for dementia. Adv Psychiatr Treat. 2001;7:24-31.
16. Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166(4):367-78.
17. Saunders PA, Copeland JRM, Dewey ME, Davidson IA, McWilliam C, Sharma V, et al. Heavy drinking as a risk factor for depression and dementia in elderly men: findings from the Liverpool longitudinal community study. Br J Psychiatry. 1991;159:213-6.
18. Santibanez M, Bolumar F, Garcia AM. Occupational risk factors in Alzheimer's disease: a review assessing the quality of published epidemiological studies. Occup Environ Med. 2007;64(11):723-32.
19. Gustafson D. Adiposity indices and dementia. Lancet. 2006;5:713-20.
20. Luchsinger JA, Gustafson DR. Adiposity and Alzheimer's disease. Curr Opin Clin Nutr Metab Care. 2009;12:15-21.
21. Jellinger KA. Head injury and dementia. Curr Opin Neurol. 2004;17:719-23.
22. Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, Kuslansky G, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med. 2003;348(25):2508-16.
23. Wang H-X, Karp A, Winblad B, Fratiglioni L. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the kungsholmen project. Am J Epidemiol. 2002;155(12):1081-7.
24. Karp A, Kåreholt I, Qiu C, Bellander T, Winblad B, Fratiglioni L. Relation of education and occupation-based socioeconomic status to incident of Alzheimer's disease. Am J Epidemiol. 2004;159:175-83.
25. Kalmijn S, Launer LJ, Ott A, Witteman JCM, Hofman A, Breteler MMB. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol. 1997;42(5):776-82.
26. Nourhashemi F, Gillette-Guyonnet S, Andrieu S, Ghisolfi A, Ousset PJ, Grandjean H, et al. Am J Clin Nutr. 2000;71(2):643s-9.
27. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58(3):498-504.
28. Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth Jr WT, Mittleman MA, Siscovick D. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA. 2003;289(11):1405-13.
29. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10(9):819-28.
30. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry. 2001;35:776-81.
31. Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry. 2012;69(5):493-8.
32. Biringer E, Mykletun A, Dahl AA, David Smith A, Engedal K, Nygaard HA, et al. The association between depression, anxiety, and cognitive function in the elderly general population - the Hordaland Health Study. Int J Geriatr Psychiatry. 2005;20:989-97.
33. Jorm AF. Is depression a risk factor for dementia or cognitive decline? A review. Gerontology. 2000;46:219-27.
34. Gallacher J, Bayer A, Fish M, Pickering J, Pedro S, Dunstan F, et al. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study. Psychosom Med. 2009;71(6):659-66.
35. Jacobi F, Wittchen H-U, Holting C, Hofler M, Pfister H, Muller N, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German health interview and examination survey (GHS). Psychol Med. 2004;34(4):597-612.
36. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):617-27.
37. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol. 1991;100(3):316-36.
38. Johansson L, Guo X, Waern M, Östling S, Gustafson D, Bengtsson C, et al. Midlife psychological stress and risk of dementia: a 35-year longitudinal population study. Brain. 2010;133(8):2217-24.
39. Johansson L, Guo X, Hällström T, Norton MC, Waern M, Östling S, et al. Common psychosocial stressors in middle-aged women related to longstanding distress and increased risk of Alzheimer's disease: a 38-year longitudinal study. BMJ Open. 2013;3:1-7.
40. Russ TC, Hamer M, Stamatakis E, Starr JM, Batty G. Psychological distress as a risk factor for dementia death. Arch Intern Med. 2011;171(20):1859-9.
41. Krokstad S, Langhammer A, Hveem K, Holmen TL, Midthjell K, Stene TR, et al. Cohort profile: the HUNT study, Norway. Int J Epidemiol. 2013;42 (4):968-77.
42. Holmen J, Midthjell K, Forsén L, Skjerve K, Gorseth M, Oseland A. A health survey in Nord-Trøndelag 1984-86. Participation and comparison of attendants and non-attendants. Tidsskrift for den norske Legeforening. 1990;110(15):1973-7.
43. Holmen J, Midthjell K, Krüger O, Langhammer A, Holmen TL, Bratberg GH, et al. The nord-trøndelag health study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi. 2003;13(1):19-32.
44. Bjerkeset O, Romundstad P, Evans J, Gunnell D. Association of adult body mass index and height with anxiety, depression, and suicide in the general population: the hunt study. Am J Epidemiol. 2008;167(2):193-202.
45. Bjerkeset O, Nordahl HM, Mykletun A, Holmen J, Dahl AA. Anxiety and depression following myocardial infarction: gender differences in a 5-year prospective study. J Psychosom Res. 2005;58(2):153-61.
46. Cosco TD, Doyle F, Ward M, McGee H. Latent structure of the hospital anxiety and depression scale: a 10-year systematic review. J Psychosom Res. 2012;72(3):180-4.
47. Bergh S, Holmen J, Gabin J, Stordal E, Fikseaunet A, Selbaek G, et al. Cohort profile: the Health and Memory Study (HMS): a dementia cohort linked to the HUNT study in Norway. Int J Epidemiol. 2014;43(6):1759-68.
48. WHO. ICD-10. International statistical classification of diseases and related health problems. Geneva: World Health Organization; 2005.
49. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47(5):1113-24.
50. Neary D, Snowden JS, Mann DM. Classification and description of frontotemporal dementias. Ann N Y Acad Sci. 2000;920:46-51.
51. Stata Corp. Stata Statistical Software: Release 12. College Station, TX: Stata Corp LP; 2011.
52. Muthén LK, Muthén BO. Mplus user's guide. 3rd ed. Los Angeles: Muthén & Muthén; 1998-2004.
53. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18(4):351-7.
54. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ. Sequence of deposition of heterogeneous amyloid β-peptides and apo e in down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis. 1996;3(1):16-32.
55. Wilson RS, Evans DA, Bienias JL, de Leon CF M, Schneider JA, Bennett DA. Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology. 2003;61(11):1479-85.
56. Alexopoulus GS, Bruce ML, Silbersweig D, Kalayan B, Stern E. Vascular depression: a new view of late-onset depression. Dialogues Clin Neurosci. 1999;1(2):68-80.
57. Alexopoulos GS. The vascular depression hypothesis: 10 Years Later. Biol Psychiatry. 2006;60(12):1304-5.
58. Westerlund H, Gustafsson PE, Theorell T, Janlert U, Hammarström A. Social adversity in adolescence increases the physiological vulnerability to Job strain in adulthood: a prospective population-based study. PLoS ONE. 2012;7(4):e35967. doi: 10.1371/journal.pone.0035967 (pp. 1-8).
59. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 Suppl 5):S10-5.
60. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63(5):530-8.
61. Hynd MR, Scott HL, Dodd PR. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int. 2004;45(5):583-95.
62. Lara VP, Caramelli P, Teixeira AL, Barbosa MT, Carmona KC, Carvalho MG, et al. High cortisol levels are associated with cognitive impairment no-dementia (CIND) and dementia. Clin Chim Acta. 2013;423:18-22.
63. van der Flier WM, Pijnenburg YAL, Fox NC, Scheltens P. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ϵ4 allele. Lancet Neurol. 2011;10(3):280-8.
64. Koedam ELGE, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YAL. Early-versus late-onset Alzheimer's disease: more than age alone. J Alzheimers Dis. 2010;19(4):1401-8.
65. Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, et al. Effect of age at onset on the course of major depressive disorder. A J Psychiatry. 2007;164(10):1539-46.
66. McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology. 2000;22(2):108-24.
67. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the nun study. JAMA. 1997;277(10):813-7.
68. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329-35.
69. Sampson EL, Blanchard MR, Jones L, Tookman A, King M. Dementia in the acute hospital: prospective cohort study of prevalence and mortality. Br J Psychiatry. 2009;195(1):61-6.
70. Johansson L, Guo X, Hällström T, Norton MC, Waern M, Östling S, et al. Common psychosocial stressors in middle-aged women related to longstanding distress and increased risk of Alzheimer's disease: a 38-year longitudinal population study. BMJ Open. 2013;3:9 e003142. doi:10.1136/bmjopen-2013-003142 (pp. 1-7).
71. Cuijpers P, Van Straten A, Smit F. Preventing the incidence of new cases of mental disorders: a meta-analytic review. J Nerv Ment Dis. 2005;193(2):119-25.
72. Cuijpers P, Beekman ATF, Reynolds CF. Preventing depression: a global priority. JAMA. 2012;307(10):1033-4.